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Background: Bacterial Disulfide bond forming (Dsb) proteins facilitate proper folding and disulfide bond formation
of periplasmic and secreted proteins. Previously, we have shown that Mycobacterium tuberculosis Mt-DsbE and
Mt-DsbF aid in vitro oxidative folding of proteins. The M. tuberculosis proteome contains another predicted
membrane-tethered Dsb protein, Mt-DsbA, which is encoded by an essential gene.
Results: Herein, we present structural and biochemical analyses of Mt-DsbA. The X-ray crystal structure of Mt-DsbA
reveals a two-domain structure, comprising a canonical thioredoxin domain with the conserved CXXC active site
cysteines in their reduced form, and an inserted α-helical domain containing a structural disulfide bond. The overall
fold of Mt-DsbA resembles that of other DsbA-like proteins and not Mt-DsbE or Mt-DsbF. Biochemical
characterization demonstrates that, unlike Mt-DsbE and Mt-DsbF, Mt-DsbA is unable to oxidatively fold reduced,
denatured hirudin. Moreover, on the substrates tested in this study, Mt-DsbA has disulfide bond isomerase activity
contrary to Mt-DsbE and Mt-DsbF.
Conclusion: These results suggest that Mt-DsbA acts upon a distinct subset of substrates as compared to Mt-DsbE
and Mt-DsbF. One could speculate that Mt-DsbE and Mt-DsbF are functionally redundant whereas Mt-DsbA is not,
offering an explanation for the essentiality of Mt-DsbA in M. tuberculosis.
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OxidoreductaseBackground
Correct folding and disulfide bond formation is essential
for the function of many secreted proteins including bac-
terial toxins, and their formation is facilitated by disulfide
bond forming (Dsb) oxidoreductase proteins, which usu-
ally contain a conserved thioredoxin (TRX) fold [1]. Pro-
tein disulfide bonds can serve structural roles, and thus
are often buried in the core of a protein. However, in the
case of Dsb proteins, partially exposed disulfide bonds in
the TRX-fold CXXC motif have catalytic roles in protein
folding, electron transport and bioenergetics in a variety of
organisms [2,3].* Correspondence: celia.goulding@uci.edu
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reproduction in any medium, provided the orThe Dsb proteins of Escherichia coli are the best charac-
terized, and reside in its periplasm to correctly fold disul-
fide bond containing secreted and cell-wall proteins [4].
E. coli DsbA (Ec-DsbA) catalyzes the oxidation of disulfide
bonds in reduced, unfolded proteins [5,6], and is then re-
oxidized by ubiquinone via E. coli DsbB (Ec-DsbB), an
inner membrane transmembrane protein, which in turn is
oxidized by the electron transport pathway [7,8]. E. coli
DsbC (Ec-DsbC) and E. coli DsbG (Ec-DsbG) serve as
proofreading disulfide isomerases that are able to break
and correctly reform non-native protein disulfide bonds,
thus ensuring that these important secreted proteins are
functionally active [9,10]. E. coli DsbD (Ec-DsbD) is re-
sponsible for maintaining Ec-DsbC and Ec-DsbG in their
active redox states and is a transmembrane protein also
spanning the inner membrane [11]. Finally, E. coli DsbE
(Ec-DsbE) is a reductant involved in cytochrome c matur-
ation [12], its redox partner is also proposed to be Ec-td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prokaryotes [2], including gram-positive bacteria where
they also appear to be widespread. As gram-positive bac-
teria have no spatially defined periplasmic compartment,
the precise function and membrane bound redox partners
of these Dsb-like proteins appear to differ from those of
gram-negative bacteria [14].
Dsb proteins, and in particularly DsbA, have been
shown to be involved in virulence of toxin-secreting gram-
negative bacteria such as Yersinia pestis [15], Shigella sp.
[16], Vibrio cholerae [17,18] and E. coli [19]. Mycobacter-
ium tuberculosis (Mtb) is a pathogenic bacterium respon-
sible for tuberculosis (TB), which causes approximately 1.4
million deaths and 8 million new cases per year [20]. Mtb
secreted proteins have many different functions including
those associated with virulence, pathogenicity and cell-wall
maintenance. Within the Mtb proteome, it has been pre-
dicted that over 180 proteins are secreted, of which ~ 60%
may contain disulfide bonds based on their cysteine con-
tent, thus suggesting that Dsb proteins may play an im-
portant role in the correct folding of secreted proteins [21].
Mtb EspA is one such secreted protein that may require
the folding assistance of Mtb Dsb proteins. The single di-
sulfide bond within Mtb EspA has been found to have an
important role in disease progression in mice as well as
maintaining cell wall integrity [22], highlighting a crucial
link between disulfide bond formation and virulence in
Mtb. One could speculate that interruption of the Mtb
Dsb-assisted folding pathways may prevent mycobacterial
infectivity and viability. Therefore, the study of Mtb Dsb
protein systems may offer new insight into its virulence
and may provide novel anti-TB drug targets.
In Mtb, there are thought to be two distinct Dsb sys-
tems, shown in Figure 1. The first system is proposed to
have two periplasmic proteins, Mtb DsbE (Mt-DsbE,
Rv2878c) and DsbF (Mt-DsbF, Rv1677), and their inner
membrane redox partner is thought to be Mtb DsbD
(Mt-DsbD, Rv2874) [21] or Rv2877c [23]. Unlike the re-
ductant Ec-DsbE [24], both Mt-DsbE and Mt-DsbF are
oxidants as confirmed by their ability to oxidatively fold
hirudin [21,25]. The second proposed oxidoreductase
system is the Mtb Rv2969c/Rv2968c system [26-28];
Rv2968c is annotated as a vitamin K epoxide reductase
(Mt-VKOR) and Rv2969c as a hypothetical protein [29].
As Rv2969c has high sequence identity to gram-positive
bacterial DsbA homologs, Bacillus subtilis BdbD (Bs-
BdbD) and Staphylococcus aureus DsbA (Sa-DsbA)
[30,31], we shall refer to Rv2969c as Mt-DsbA hereafter.
A recent report suggests that Mt-DsbA both localizes
on the mycobacterial surface and is associated with
the membrane [32], and thus is probably membrane-
tethered. Since Rv2968c and Rv2969c are within the
same operon and because Mt-VKOR can functionally
substitute Ec-DsbB in vivo [27,28], Mt-VKOR and Mt-DsbA may function together [33]. Interestingly, an ex-
haustive transposon mutagenesis study showed that the
genes encoding Mt-VKOR and Mt-DsbA are essential
for optimal Mtb growth, whereas Mt-DsbE and Mt-
DsbF are not [34], implying that Mt-DsbA is an essen-
tial Mtb protein.
In this study, we have determined the 1.9 Å-resolution
structure of the soluble form of Mt-DsbA (residues 46–
255). The overall fold of Mt-DsbA is reminiscent of Ec-
DsbA [32] and consists of two domains, a TRX domain
and an inserted α-helical domain. The Mt-DsbA TRX
domain active site CXXC motif cysteines are reduced
while a stabilizing disulfide bond is observed in the α-
helical domain [35,36]. Unlike Mt-DsbE and Mt-DsbF,
Mt-DsbA does not have the ability to catalyze the oxida-
tive folding of hirudin [21,25]. However Mt-DsbA pos-
sesses disulfide bond isomerase activity as confirmed by
its ability to catalyze the refolding of scrambled ribo-
nuclease A (scRNaseA) whereas Mt-DsbE and Mt-DsbF
do not. This study represents the structural and func-
tional characterization of an essential Mtb Dsb protein,
Mt-DsbA, and suggests that Mt-DsbA likely acts on a
distinct protein substrate set as compared to Mt-DsbE
and Mt-DsbF due to their functional differences.
Results
The structure of Mt-DsbA
Mt-DsbA is predicted to be either secreted into the peri-
plasm by a signal peptide (SignalP) [37] or tethered to the
inner membrane by an N-terminal transmembrane helix
(TMHMM) [38]. A recent paper suggested that Mt-DsbA
is a membrane-tethered protein [32], prompting the inves-
tigation of the soluble form of Mt-DsbA encoding residues
46–255, as suggested by TMHMM.
The crystal structure of the soluble form of Mt-DsbA
was solved by molecular replacement utilizing the model
of Bs-BdbD (PDB ID: 3EU3 [39]), which shares 20% se-
quence identity with Mt-DsbA, combined with the location
of two selenium atoms determined from the anomalous
data. The structure of Mt-DsbA was solved to 1.9 Å reso-
lution, with two molecules in the asymmetric unit, and the
final model had an Rwork/Rfree (%) of 20.2/23.8. Within the
asymmetric unit, residues 56–255 from monomer A and
residues 49–255 from monomer B were built into the elec-
tron density map while the remaining N-terminal residues
were presumed to be disordered as there was no observ-
able density. Monomers A and B are structurally similar
and superimpose with a root-mean-square deviation (rmsd)
of 0.5 Å. Each Mt-DsbA monomer comprises two domains
(Figure 2A), a TRX domain (residues 56–82 and 129–255)
and an inserted α-helical domain (residues 83–128), remin-
iscent of the overall fold of Ec-DsbA [40]. The TRX domain
contains the canonical CXXC motif and consists of a four-
stranded mixed β-sheet (β1-4) decorated with four α-
Figure 1 Two parallel oxidoreductase systems are depicted for disulfide bond formation of Mtb secreted proteins. Mt-DsbD (Rv2874)
and/or Rv2877c are predicted to maintain the redox states of Mt-DsbE (Rv2878c) and Mt-DsbF (Rv1677) while Mt-VKOR (Rv2968c) is proposed to
maintain the redox state of its genomic neighbor, Mt-DsbA (Rv2969c).
Figure 2 Crystal structure of Mt-DsbA reveals a DsbA-like fold. A. Cartoon representation of Mt-DsbA reveals a two-domain structure
comprising a TRX domain (colored in pink for β-strands, cyan for α-helices and salmon for loops) and an inserted α-helical domain (colored in red
for α-helices and green for loops). The overall fold is reminiscent of DsbA-like homologs. The CXXC motif cysteines, Cys89 and Cys92, are
reduced, while the α-helical domain cysteines, Cys140 and Cys192, form a disulfide bond. B. 2Fo-Fc electron density mesh (grey) of the active site
CXXC cysteine residues contoured at 1σ. C. The reduced CXXC form of Mt-DsbA is stabilized by hydrogen bonds (designated with black dashed
lines) to Thr214 of the cis-Pro loop.
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tween β3 and α6 of the TRX domain comprises four α-
helices (α2-5), and is stabilized by a structural disulfide
bond between helices α2 and α5 (Cys140 and Cys192 with
a Sγ - Sγ distance of 2.1 Å), despite 100 mM DTT in the
crystallization condition. The long helix α6 transitions from
the α-helical domain back to the TRX domain. The CXXC
active site cysteines, adopt a right-handed hook conform-
ation at the N-terminal of helix α1 where the solvent ex-
posed Cys89 and solvent buried Cys92 are reduced with a
distance of 3.7 Å between the two Sγ atoms (Figure 2B).
The Mt-DsbA cis-Pro loop (Thr214-Pro215-Thr216), a
conserved feature within the redox-active TRX family, in-
teracts with the CXXC motif throughThr214, which hydro-
gen bonds to both Cys89 and Cys92 (Figure 2C). The Sγ
atom of Cys92 is stabilized by weak hydrogen bonds to the
amide N atom of Asp86 (3.6 Å), the Thr214 hydroxyl
Oγ atom (3.7 Å) while the Sy atom of Cys89 is hydrogen
bonded to the Thr214 hydroxyl Oγ atom (3.2 Å) and its
backbone carbonyl O atom (3.6 Å). Additionally, Cys89
is hydrogen bonded to two water molecules (W1 & W2,
Figure 2C), and one of these waters (W1) in turn forms a
hydrogen bond with Thr214 hydroxyl Oγ atom and its
backbone carbonyl O atom.
Mt-DsbA has structural similarity to other bacterial
DsbA proteins
A structural homology search using the DALI server
[41] showed that Mt-DsbA has high structural homology
with bacterial DsbA-like proteins (Figure 3F). The two
closest structural homologs to Mt-DsbA (Figure 3A) are
gram-positive bacteria, Bs-BdbD (Figure 3B) [30] and
Sa-DsbA (Figure 3E) [31] with rmsd values of 2.6 Å
over 186 Cα atoms and 2.2 Å over 165 Cα atoms, re-
spectively. Of note, Bs-BdbD contains a novel metal
binding site at an interdomain position [30], which is
not observed in other DsbA homologs (Figure 3B). The
next closest structural homolog is a DsbA-like protein
from gram-negative bacteria Wolbachia pipientis (Wp-
DsbA, Figure 3D) [42], which also contains a structural
disulfide bond in its inserted α-helical domain as ob-
served for Mt-DsbA [42]. Ec-DsbA also has structural
homology with Mt-DsbA with an rmsd of 3.6 Å over
188 Cα atoms (Figure 3C) [43]. There are two main
distinct structural features of Mt-DsbA compared to
the above DsbA homologs. First Mt-DsbA has an extra
C-terminal helix (α8), Figures 2A & 3G. Second, within the
inserted α-helical domain there are two extended loop
regions connecting β3 to α2, and α3 to α4, both within the
vicinity of the CXXC active site (Figures 2A & 3G). Further,
the outer β-strands of the central β-sheet of the TRX
domain varies between Ec-DsbA and Mt-DsbA (as well as
Bs-BdbD, Sa-DsbA and Wp-DsbA), where Mt-DsbA has an
extra strand (β1) at the N-terminal of its β-sheet comparedto Ec-DsbA, while Ec-DsbA has two extra β-strands at the
C-terminal of its β-sheet compared to Mt-DsbA. Addition-
ally, Ec-DsbA has an extended loop region between its C-
terminal β-strand and α-helix, which contributes to the
formation of the deep CXXC hydrophobic binding pocket
(elaborated upon in the discussion) required for its inter-
action with Ec-DsbB [44] but not present in Mt-DsbA or
the other DsbA homologs (Figure 3).
Mt-DsbA cannot oxidatively fold reduced and
denatured hirudin
Since Mt-DsbE and Mt-DsbF have the ability to oxida-
tively fold reduced and denatured Hirudo medicinalis hi-
rudin [21,25], we tested if Mt-DsbA is able to function
similarly. The thrombin inhibitor, hirudin, is a 6.9 kDa
protein that contains three intramolecular disulfide bonds.
MALDI-TOF mass spectrometry analysis of commercial
native hirudin revealed significant impurities as well as a
major hirudin peak (m/z 6765) followed by several smaller
hirudin peaks ranging up to m/z 7088, consistent with
previous reports that hirudin is a non-homogenous pro-
tein that contains several variants [45]. Reverse-phase
HPLC was used to enhance the homogeneity of the m/z
6765 peak as well as remove most contaminating proteins.
MALDI-TOF mass spectrometry of HPLC-purified redu-
ced, unfolded hirudin showed a uniform m/z increase of 6
Da. Furthermore, the addition of iodoacetamide to re-
duced, unfolded hirudin carbamidomethylated the free
cysteines and resulted in a mass increase of six 57-Da in-
crements (+ 342 Da mass). Thus, the major MALDI-TOF
peak was used to monitor the regeneration of reduced, un-
folded hirudin (~1.5 pmol) to the fully oxidized native
state in the absence and presence of greater than three
molar equivalents of Mt-DsbA, Mt-DsbF or Ec-DsbA. At
various time points, samples from the folding assay were
quenched by the addition of iodoacetamide and analyzed
by MALDI-TOF mass spectrometry. The appearance of
native hirudin (m/z 6765) is represented as a percentage of
the total intensities of native and carbamidomethylated
hirudin. In the absence of Dsb protein, a small fraction of
native hirudin was observed after 8 hours (Figure 4A), pre-
sumably due to spontaneous, air-mediated oxidation [21].
As previously reported, Mt-DsbF is able to reoxidize
hirudin, and after 8 hours of incubation with Mt-DsbF,
approximately 70% of hirudin was in its native state com-
pared to 100% when incubated with Ec-DsbA [25]. In
contrast, after an 8-hour incubation with Mt-DsbA, a small
fraction of native hirudin equivalent to that of the spontan-
eous oxidative folding of hirudin in the absence of Dsb
protein was observed (Figure 4A).
Mt-DsbA does not have the ability to reduce insulin
Insulin contains two polypeptide chains (A and B) and
has one intramolecular and two intermolecular disulfide
Figure 3 Structural homologs of Mt-DsbA and sequence alignment. Structures in panels A-E are shown in cartoon representation with the
CXXC (designated with a red arrow) and structural disulfide bond (designated with a green circle) shown in stick representation with sulfur atoms
color in yellow. The blue circle represents the Ca2+-binding site of Bs-BdbD and the red circles represent the distinct structural differences
between the DsbA-like proteins. A. Mtb DsbA (Mt-DsbA, PDB ID: 4IHU) colored in blue B. B. subtilis BdbD (Bs-BdbD, PDB ID: 3EU3, [30]) colored in
pink C. E. coli DsbA (Ec-DsbA, PDB ID: 1DSB, [40]) colored in green D. W. pipientis α-DsbA (Wp-DsbA, PDB ID: 3F4T, [42]) colored in orange,
E. S. aureus DsbA (Sa-DsbA, PDB ID: 3BCI, [31]) colored in yellow F. Superimposition of Mt-DsbA with the other four DsbA homologs in ribbon
representation. G. Overall sequence and structural comparison of Mt-DsbA, Bs-BdbD, Sa-DsbA, Wp-DsbA and Ec-DsbA. The sequences are less
than 20% identical and the conserved CXXC and cis-Pro loop motifs are highlighted in blue. Boxed regions correspond to insertions that
contribute to structural differences in the respective homolog sequence, red for Mt-DsbA and green for Ec-DsbA. Secondary-structure elements
for Mt-DsbA are depicted on the top line.
Chim et al. BMC Structural Biology 2013, 13:23 Page 5 of 14
http://www.biomedcentral.com/1472-6807/13/23bonds. Reduction of these disulfide bonds results in the
dissociation of chains A and B, where chain B is insol-
uble and aggregates. Thus, the reduction of insulin may
be assessed by following the increase in turbidity at 650
nm, which is due to the aggregation of chain B and can
be determined in the presence and absence of a disulfide
reductase. We determined the rate of insulin reduction
in the presence of either Mt-DsbA, Mt-DsbE, Mt-DsbFor positive controls (Ec-DsbA and Ec-DsbC). Ec-DsbC
and Ec-DsbA both possess insulin reductase activity;
however Ec-DsbC is a stronger reductase than Ec-DsbA
(Figure 4B). In contrast, in the presence of Mt-DsbA, Mt-
DsbE and Mt-DsbF insulin exhibited basal-levels of aggre-
gation similar to that of insulin in the absence of Dsb
protein, suggesting that these Dsb proteins are unable to
reduce insulin under the conditions tested (Figure 4B).
Figure 4 Biochemical characterization of Mt-DsbA. A. Mt-DsbA does not facilitate correct disulfide bond formation and folding of denatured
hirudin, whereas Mt-DsbF and Ec-DsbA do. B. Mt-DsbA does not possess insulin reductase activity as observed for Mt-DsbE and Mt-DsbF. In
contrast, Ec-DsbC possesses disulfide reductase activity, and Ec-DsbA has reduced reductase activity in comparison to Ec-DsbC. C. In vitro Dsb
protein isomerase activity was assessed by using the scrambled RNaseA (scRNaseA) refolding assay. Mt-DsbA has disulfide bond isomerase activity
in contrast to Mt-DsbE and Mt-DsbF, which do not possess the ability to refold scRNaseA. The fraction of native RNaseA activity were calculated
and plotted against incubation time.
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Mt-DsbA contains some residues characteristic of the E.
coli disulfide bond isomerases Ec-DsbC and Ec-DsbG (Asp
in the DXXCXYC motif, Thr in cis-Pro loop). To deter-
mine whether Mt-DsbA has isomerase activity, we tested
Mt-DsbA catalyzed recovery of active RNaseA from oxi-
dized, disulfide-scrambled RNaseA (scRNaseA). This assay
revealed that Mt-DsbA possesses scRNaseA isomerase ac-
tivity and the active site CXXC cysteines are required for
activity, as Cys89Ser and Cys92Ser mutations render
Mt-DsbA inactive (Figure 4C). However, the structural
disulfide bond in the inserted α-helical domain does not
play a role in this activity as the Cys140Ser and
Cys192Ser mutants retain similar isomerase activity to
wild-type Mt-DsbA (Figure 4C). Of note, Wp-DsbA also
contains a structural disulfide bond in its α-helical
domain (Figure 3D), and mutation of these cysteines to
alanines does not affect its disulfide bond isomerase
activity [42], as observed for Mt-DsbA. Moreover, nei-
ther Mtb-DsbE nor Mt-DsbF can catalyze the refolding
of scRNaseA to produce active RNaseA, and thus do
not appear to have isomerase activity under the condi-
tions tested (Figure 4C). These results demonstrate that
Mt-DsbA has protein disulfide isomerase activity, while
Mt-DsbE and Mt-DsbF do not possess this activity on
the substrates tested in this study.
Discussion
Comparisons of molecular surfaces and functions of
DsbA-like proteins to Mt-DsbA
The electrostatic molecular surface representation of Mt-
DsbA (Figure 5A) reveals a shallow hydrophobic pocket at
the CXXC active site surrounded by negatively charged
patches. The residues that contribute to the negativelyFigure 5 Electrostatic molecular surface of Mt-DsbA compared to oth
negative charges around the hydrophobic active site. B. Ec-DsbA, PDB ID: 1
[42]. Positive and negative electrostatic potentials, shown in blue (+3.0 kT/e
containing the conserved CXXC motifs.charged patch above the CXXC motif are within the α-
helical domain, Asp123, Glu165 and Asp169, from the two
extended loops as well as Asp203 and Glu200 from α5
helix, whereas residues that contribute to the negative patch
below the CXXC motif are from the TRX domain, Glu233
and Glu225, positioned in the loop region connecting β4 to
α7. For Ec-DsbA (Figure 5B), the characteristic surface
features include a deep hydrophobic groove formed by an
extended loop region connecting the C-terminal β-strand
and α-helix (Figure 3B), which interacts with a periplasmic
loop of its redox partner, Ec-DsbB [46]. Furthermore, an
additional hydrophobic patch above the CXXC is thought
to be important for binding unfolded protein substrates
[44,47]. Similar surface charge and architecture is seen in
other gram-negative DsbA proteins such as V. cholerae
TcpG [17] and Neisseria meningitidis NmDsbA3 [48], as
compared to Ec-DsbA. The gram-positive bacterial Sa-
DsbA (Figure 5C) also has a shallow hydrophobic pocket at
the CXXC motif as well as a negative patch directly above
its CXXC motif; however this negative patch is not as
extensive as the one observed for Mt-DsbA (Figure 5A). Of
note, Wp-DsbA has a basic electrostatic surface and deep
binding groove near its CXXC motif (Figure 5D).
The residues surrounding the CXXC active site motifs
are similar among the DsbA-like proteins, however there
are subtle differences that may modulate substrate recogni-
tion and reactivity. Within Mt-DsbA, Sa-DsbA and Wp-
DsbA (Figures 6A, C & D), the residue preceding cis-Pro is
a Thr, whereas the corresponding Ec-DsbA residue is Val
(Figure 6B). In Mt-DsbA, the hydrogen bond between the
amide proton of Asp86 and thiolate of Cys89 is also ob-
served in Sa-DsbA (Figure 6C), whereas Asp is substituted
with a Ser residue at this position in both Ec-DsbA and
Wp-DsbA (Figures 6B & D). The loop region above theer DsbA homologs. A. Mt-DsbA (PDB ID: 4IHU) reveals strong
DSB, [40] C. Sa-DsbA, PDB ID: 3BCI, [31] D. Wp-DsbA, PDB ID: 3F4T,
) and red (−3.0 kT/e), respectively. S represents the active sites
Figure 6 Comparison of the active sites of DsbA-like proteins. Proteins are in cartoon representation with notable residues in stick
representation, with oxygen, nitrogen and sulfur colored red, blue and yellow, respectively. In panels B-D, active site waters are not shown for
clarity. A. Mt-DsbA (PDB ID: 4IHU) in blue and waters are depicted as red spheres. B. Ec-DsbA (PDB ID: 1DSB, [40]) in green superimposed upon
Mt-DsbA in blue, residue numbering for Ec-DsbA. C. Sa-DsbA (PDB ID: 3BCI, [31]) in salmon superimposed upon Mt-DsbA in blue, residue
numbering for Sa-DsbA. D. Wp-DsbA (PDB ID: 3F4T, [42]) in orange superimposed upon Mt-DsbA in blue, residue numbering for Wp-DsbA.
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Asp123 in Mt-DsbA (Figure 6A), also observed for Wp-
DsbA (Figure 6D), whereas for both Ec-DsbA and Sa-
DsbA the charged Asp residue is substituted with Gly
(Figures 6B & C). Finally, the third water molecule (W3)
observed within the active site vicinity of Mt-DsbA is
hydrogen bonded to another water (W2) and also to
Glu165, which contributes to the negative molecular sur-
face surrounding the CXXC motif (Figure 6A). A position-
ally equivalent glutamate residue near the CXXC motif is
also observed within the structure of Sa-DsbA (Figure 6C)
whereas in Ec-DsbA, Glu165 is substituted by Gln that is
not surface-exposed (Figure 6B) and the corresponding
residue is Tyr120 in Wp-DsbA, which is considerably
further away from the active site as compared to Glu165
of Mt-DsbA (Figure 6D).
Ec-DsbA can catalyze the reduction of insulin in the
presence of DTT [42]; in contrast, Mt-DsbA does not show
such activity, which may be a consequence of its less
hydrophobic patch above the CXXC active site motif(Figures 5A & B). Previous studies of Sa-DsbA demonstrate
that, like Mt-DsbA, it has no ability to catalyze the reduc-
tion of insulin [31], and both Mt-DsbA and Sa-DsbA have
a similar negatively charged molecular surface above the
CXXC motif (Figures 5A & C). However, when the pre-
ceding cis-Pro Sa-DsbA residue, Thr153 was mutated to
Val as observed in the Ec-DsbA cis-Pro loop (Figures 3G,
6B & C), some insulin reduction activity was restored
while Sa-DsbA isomerase activity remained unchanged. In
the Wp-DsbA study [42], a similar Thr to Val mutation in
the cis-Pro motif (Figure 6D) also demonstrated more
insulin reductase activity together with reduced isomerase
activity compared to wild-type Wp-DsbA, and the Wp-
DsbA Thr172Val mutant has a similar activity profile as
Ec-DsbA [42]. These observations suggest that the residue
preceding cis-Pro influences substrate recognition and, in
part the activities of Dsb proteins, leading to the specula-
tion that lack of insulin reduction activity for Mt-DsbA
may also result from disruption of substrate binding at the
negatively charged patch (Figure 5A).
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DsbE and Mt-DsbF
Three secreted or membrane-tethered Mtb Dsb proteins
have been structurally and biochemically studied, Mt-
DsbE [21], Mt-DsbF [25] and in this study, Mt-DsbA.
While Mt-DsbE and Mt-DsbF are structurally similar with
an rmsd of 1.0 Å (Figure 7C), Mt-DsbA is structurally dis-
tinct (Figures 7D & E). Firstly, Mt-DsbE and Mt-DsbF
both consist of one TRX-like domain comprising a five
stranded anti-parallel β-sheet decorated by four α-helices
(Figures 7A & B) and an additional N-terminal region. In
contrast, Mt-DsbA consists of two domains (Figures 2A &
7D) and has an overall fold reminiscent of Ec-DsbA [40].
While the core TRX fold for all three Mtb Dsb proteins is
conserved, the TRX domains of both Mt-DsbE and Mt-
DsbF are more complex compared to that of Mt-DsbA.
Both Mt-DsbE and Mt-DsbF have an additional N-terminal
region comprising a short 310-helix followed by a β-hairpin
and another short 310-helix, and their central β-sheets
contain an initial extra β-strand to produce five stranded
antiparallel β-sheets compared to the four stranded mixed
β-sheet observed for Mt-DsbA. Finally, Mt-DsbA has an
extra C-terminal α-helix (α8), which is not present in
the structures of Mt-DsbE or Mt-DsbF (Figure 7E).
Additionally, the electrostatic molecular surface sur-
rounding the catalytic CXXC motif of Mt-DsbA isFigure 7 Mt-DsbA is structurally dissimilar from Mt-DsbE and Mt-Dsb
the CXXC motif and structural cysteines shown in stick representation. A. M
colored in cyan, C. Superimposition of Mtb-DsbE and Mt-DsbF results in an
E. Superimposition of Mt-DsbA with Mtb-DsbE or Mt-DsbF results in the samore negatively charged than those observed for either
Mt-DsbE or Mt-DsbF [25].
Besides structural differences, Mt-DsbA exhibits func-
tional differences compared to Mt-DsbF and Mt-DsbE.
Both Mt-DsbE and Mt-DsbF can oxidatively fold re-
duced and denatured hirudin [21,25] whereas Mt-DsbA
does not possess this activity. In contrast, only Mt-
DsbA exhibits isomerase/oxidizing activity on the sub-
strate, scRNaseA. These results suggest two features
that differentiate Mt-DsbA from Mt-DsbE and Mt-
DsbF. First, Mt-DsbA probably functions on a separate
subset of Mtb substrates compared to Mt-DsbE and Mt-
DsbF. Second, one could postulate that Mt-DsbE and
Mt-DsbF have redundant activities even though they
have negatively correlated gene expression profiles [25],
whereas Mt-DsbA is the sole protein to carry out its
unique function in the Mtb Dsb system (Figure 1), and
thus Rv2969c is an essential gene [34].
Since Rv2968c and Rv2969c are within the same operon
and because Mt-VKOR can functionally substitute Ec-DsbB
in vivo [27,28] and is part of the disulfide bond formation
pathway [26], we suggest that membrane-bound Mt-VKOR
is responsible for maintaining the redox state of its genomic
neighbor, Mt-DsbA. The structure of Synechococcus sp.
VKOR in complex with its naturally fused thioredoxin-like
protein has been solved [49]. We constructed a model ofF. Structures in panels A-E are shown in cartoon representation with
t DsbE (PDB ID: 1LU4) colored in light pink, B. Mt-DsbF (PDB ID: 3IOS)
rmsd of 1.0 Å over all Cαs. D. Mt-DsbA (PDB ID: 4IHU) colored in blue,
me rmsd of 3.4 Å over all Cαs.
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ID: 3KP9) and modeled Mt-DsbA interacting with the Mt-
VKOR loop region which contains two of the four cysteines
required for full activity of Mt-VKOR [27], Figure 8A. Inter-
estingly, a previous study has shown that the activity of Mt-
VKOR can be inhibited by warfarin, an anticoagulant [27],
while another study has shown that small molecules can
bind another DsbA-like protein,V. cholerae TcpG [50]. As
Mt-DsbA and Mt-VKOR are both essential Mtb pro-
teins [34] and are susceptible to small molecules bind-
ing, we propose that they may be good candidates for
Mtb drug discovery.
Implications for Mt-DsbA in host-pathogen interactions
A previous study demonstrated that Mt-DsbA localized on
the Mtb membrane in vitro, and that it also contains sev-
eral host-cell binding regions [32]. A twenty amino acid
Mt-DsbA peptide was used to produce antibodies that
demonstrated that Mt-DsbA is exposed on the mycobac-
terial cell surface. This peptide includes α-helix (α3) within
the inserted α-helical region (Figure 8B) and contains many
charged residues exposed on the molecular surface of Mt-
DsbA. Additionally, it was shown that two other twenty
amino acid peptides of Mt-DsbA, one from the N-terminal
region (including the first β-strand, β1) and the other from
the C-terminal region (including the final α-helix, α8),
Figure 2A, have the ability to bind to epithelial cells and
inhibit Mtb invasion of these cells in a dose-dependent
manner at high micromolar concentrations.Figure 8 Mt-DsbA regions proposed to be important for Mt-VKOR int
VKOR/TRX structure (PDB ID: 3KP9) [49], SWISS-MODEL [51] was used to con
DsbA and Mt-VKOR. B. The cartoon representation of Mt-DsbA where whit
produce an antibody that recognized Mt-DsbA on the Mtb cell surface [32Conclusions
In this study, we show that Mt-DsbA is structurally dis-
tinct from Mt-DsbE and Mt-DsbF. Additionally, unlike
Mt-DsbE and Mt-DsbF, Mt-DsbA is unable to oxidatively
fold reduced and denatured hirudin but can catalyze the
refolding of scRNaseA. Taken together, these results imply
that Mt-DsbA functions on a disparate set of substrates
compared to either Mt-DsbE or Mt-DsbF. Furthermore,
the knowledge that Mt-DsbA possibly facilitates mycobac-
terial interaction with host cells [32] implicates Mt-DsbA
as a potential vaccine candidate. Moreover, as both Mt-
DsbA and Mt-VKOR are encoded by essential genes [34],
interruption of the Mt-DsbA and Mt-VKOR protein-
protein interaction and its redox cycle, may greatly inhibit
mycobacterial growth and virulence. Thus further investiga-
tion into host protein/Mt-DsbA, small molecule/Mt-DsbA
and Mtb protein/Mt-DsbA interactions is warranted, as
Mt-DsbA could be an excellent target for novel anti-TB
therapeutics.Methods
Cloning and mutagenesis
Mtb Rv2969c gene was amplified from Mtb H37Rv gen-
omic DNA using KOD HotStart Polymerase Kit (EMD
Millipore) to encode residues 46–255. The 5' primer starts
with the NdeI restriction site and 3' primer (contains no
stop-codon) ends with the HindIII restriction site (Table 1).
The resulting product was excised from a 2% agarose geleractions and antibody production. A. Using the Synechococcus sp.
struct a structural homology model of the interaction between Mt-
e stick representation indicates the 20 amino acid peptide used to
].
Table 1 Primers used to produce the Mt-DsbA construct
(residues 46–255)
Primers:
Forward 5’ CCCATATGCGCGACGACAAGAAGGACGGCGTCGCGGG 3’
Reverse 5’ CCAAGCTTGGATGTCGCGGTAGCAGCGGCCGAGTC 3’
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was ligated into a linearized blunt vector, pCR-BluntII-
TOPO (Invitrogen), and then transformed into OneShot
TOP10 E. coli cells (Invitrogen). Presence of the correct
gene was confirmed by DNA sequencing (Laguna sequen-
cing, Laguna, CA). Rv2969c was double-digested from the
blunt vector with NdeI and HindIII, and the plasmid pET30
(+) (EMD Millipore) was digested with the same restriction
enzymes. The cut Rv2969c gene was then ligated into cut
pET30 vector and transformed into E. coli BL21(DE3)-Gold
cells (Agilent). Presence of the correct gene was confirmed
by sequencing (Laguna sequencing, Laguna, CA).
The cysteine to serine mutants were constructed via
site-directed mutagenesis. The primers used are listed in
Table 2. Presence of the correct mutation was confirmed
by sequencing (Laguna sequencing, Laguna, CA).
Protein expression and purification
The mature form of Mt-DsbA residues (46–255) with a C-
terminal HisTag was overexpressed from a pET30 plasmid
containing a truncated Rv2969c gene using E. coli BL21
(DE3)-Gold cells. Cells were grown at 37°C in LB medium
containing 50 μg/ml of kanamycin. Protein expression was
induced by adding 1 mM IPTG at an OD600 ~ 0.8 and
grown for 4 h before harvesting. Cells were pelleted at
5,000 rpm for 10 min and then resuspended in wash buffer
(50 mM Tris–HCl pH 7.4, 350 mM NaCl, 10 mM imid-
azole and 10% glycerol) containing phenylmethylsulfonyl
fluoride and hen egg lysozyme, and then were lysed by son-
ication and centrifuged at 13,000 rpm for 40 min followedTable 2 Primers used for site-directed mutagenesis to
produce Cys to Ser mutants
Primers:
C89S For: 5’ CTTCTACGAGGATTTCCTGTCTCCGGCGTGCGGCATATTC 3’
Rev: 5’ GAATATGCCGCACGCCGGAGACAGGAAATCCTCGTAGAAG 3’




C140S For: 5’ CTGCTGCGGCTTATTCCGTTGCCGACGAATC 3’
Rev: 5’ GATTCGTCGGCAACGGAATAAGCCGCAGCAG 3’
C192S For: 5’ CAAGGTGCCCGACTCCATCAACAGCGGCAAG 3’
Rev: 5’ CTTGCCGCTGTTGATGGAGTCGGGCACCTTG 3’by filtration (0.22 μm) to remove cell debris before purifi-
cation. The cell lysate was loaded on to a Ni2+-charged
HiTrap column (5 mL) and washed with wash buffer be-
fore protein was eluted with a 10–500 mM linear imidazole
gradient (100 ml) in which purified Mt-DsbA eluted be-
tween 200 and 300 mM imidazole. The fractions containing
pure Mt-DsbA were collected and concentrated (Amicon,
10 kDa molecular mass cutoff) and then further purified by
gel filtration on a Superdex 200 column (GE Healthcare)
equilibrated with 20 mM Tris–HCl (pH 7.4), 150 mM NaCl
using an AKTA FPLC. The selenomethionine-derivatized
(SeMet)-Mt-DsbA was grown in M9 minimal medium
supplemented with amino acids supplements (leucine, iso-
leucine, valine, 50 mg/L; phenylalanine, lysine, threonine,
100 mg/L; and selenomethionine 75 mg/L) adapted from a
previously described protocol [52]. The SeMet-Mt-DsbA
and cysteine to serine mutants were purified as described
for native Mt-DsbA.
Crystallization, data collection and structure determination
Diffraction quality SeMet-Mt-DsbA crystals were grown at
room temperature by hanging drop-vapor diffusion with a
reservoir containing 2 M ammonium sulfate, and 9% isopro-
panol and a 75 mg/mL protein solution in 20 mM Tris–
HCl (pH 7.4), 150 mM NaCl. The crystals were mounted
and diffraction data were collected under cryoconditions by
swiping the crystal through a saturated ammonium sulfate
solution. X-ray diffraction data of a single SeMet-Mt-DsbA
crystal was collected at Beamline 5.0.2 at the Advanced
Light Source (Berkeley) to 1.9 Å, using the Se peak wave-
length of 0.97602 Å. The data were processed in iMosfilm
[53] in P21212; with unit cell dimensions of 71.0 Å ×
76.7 Å × 86.9 Å and two molecules in the asymmetric
unit. The resulting mtz file was run through SHELX [54]
to determine the location of the Se atoms. The structure of
Bs-BdbD, (PDB ID: 3EU3, [39]) was used as a model for
molecular replacement in Phaser [55] with the heavy atom
coordinates of Se from SHELX [54]. AutoBuild [56] was
used to place α-helices and β-strands. The final model of
Mt-DsbA was built through iterative manual building in
Coot [57] followed by refinement with phenix.refine [43].
The Mt-DsbA final model includes residues 56–255 and
49–255 of chains A and B (respectively), and has a final
Rwork/Rfree (%) of 20.2/23.8. Additionally, Lys168 from
monomer A, and Asp160 and Asp242 from B were mod-
eled as alanines as there was no observable electron density
for their side-chains. The stereochemistry and geometry of
each Mt-DsbA monomer was validated with PROCHECK
[58] and ERRAT [59], and was found to be acceptable, ex-
cept for Val186 from chain A and Ser227 from chain B
which despite fitting the electron density well are in the
disallowed region. The data collection and refinement sta-
tistics are presented in Table 3. All structural figures are
generated in PyMOL [46].
Table 3 X-ray diffraction data collection and atomic
refinement statistics for Mt-DsbA in its reduced form
Space group P21212
No of monomers per AS unit 2
Unit cell dimensions (Å) 71.0 × 76.7 × 86.9
pH of crystallization condition 7.4
Data set
Wavelength (Å) 0.976
Resolution range (Å) 44.70-1.90
Unique reflections (total) 38372 (706287)






Resolution range (Å) 44.70-1.90
No. of reflections (working/free) 36450/1922
Residues of Mt-DsbA Chain A 56-255
Chain B 49-255
No. of protein atoms 5975
No. of water molecules 300
Rwork/Rfree
b , % 20.2/23.8
Ramachandran plot
Most favorable region (%) 97.30
Additional allowed region (%) 2.21
Disallowed region (%) 0.49
PDB ID code 4IHU
¶Statistics for the highest resolution shell are given in (parenthesis).
a Rmerge=Σ|I-<I>|/ΣI.
b Rwork=Σ|Fobs-Fcalc|/ΣFobs Rfree was computed similarly for a test set of 5%
randomly selected data, which were not used in refinement.
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To oxidize Mt-DsbA, 50 mM of oxidized glutathione
(GSSG) was added to as-isolated Mt-DsbA in 50 mM Tris–
HCl, 150 mM NaCl and incubated for 1 hour at room
temperature. Oxidized Mt-DsbA was recovered by gel
filtration in 50 mM Tris–HCl pH 7.4, 150 mM NaCl. To
reduce Mt-DsbA, 100 mM dithiothreitol (DTT) was added
to Mt-DsbA and incubated at 4°C overnight. Reduced Mt-
DsbA was recovered by gel filtration in 50 mM Tris–HCl,
150 mM NaCl.
The redox state of the thiols was confirmed by the
Ellman’s assay, which exploits the colorimetric change at
412 nm when 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB)
is converted to 2-nitro-5-thiobenzoate upon cleavage of
the disulfide bond by free thiols. This reaction is stoichio-
metric, thus allowing for accurate quantification of free
thiols.To test for Dsb-catalyzed oxidative folding of hirudin
To test for Mt-DsbA catalyzed oxidative folding of reduced,
denatured hirudin in vitro, the experiment was carried out
as previously described [25]. Commercial H. medicinalis hi-
rudin (Sigma) was purified to remove contaminants by
reverse-phase HPLC on a Synergi 4 mm Hydro-RP column
(250 × 4.6 mm, Phenomenex) at a flow rate of 0.5 ml/min.
Solvents A and B used for reverse-phase HPLC were 0.1%
trifluoroacetic acid in water and acetonitrile, respectively.
Purified hirudin was reduced and denatured by incubation
with 100 mM DTT, 6 M Gdn-HCl overnight and eventually
desalted by ZipTip C4 (Millipore). To test for oxidative
folding of reduced, denatured hirudin, 3 molar equivalents
of oxidized Mt-DsbA (5 pmol) in 100 mM ammonium bi-
carbonate, pH 8.0 at 25°C and added to reduced, denatured
hirudin (~1.5 pmol). Each 10 μl reaction was quenched at
different time points by a 10-minute incubation at 50°C with
50 μl 6 M Gdn-HCl and followed by the addition of 0.5 μl
100 mM iodoacetamide for 15 minutes at 25°C. The samples
were then desalted by ZipTip C4 (Millipore) and analyzed by
MALDI-TOF mass spectrometry (Voyager). Experiments
were repeated with no protein and with approximately three
molar equivalents (5 pmol) of Mt-DsbF and Ec-DsbA as
positive controls. The appearance of native hirudin (m/z
6765) is represented as a percentage of the total intensities of
native and carbamidomethylated hirudin [25].
To test for Dsb-catalyzed reduction of insulin
To test for protein disulfide reductase activity of Mt-
DsbA, experiments were carried out in vitro using the
insulin reduction assay in the presence of DTT [60]. 10
μM of Ec-DsbA, Ec-DsbC (as positive controls, Sigma) or
Mt-DsbA in buffer containing 0.1 M phosphate buffer, pH
7.2, 2 mM EDTA and 0.33 mM DTT were mixed with
0.131 mM insulin to initiate the reaction. Insulin com-
prises A and B polypeptide chains connected by two disul-
fide bonds. Reduction of the disulfide bonds leads to
precipitation of the insoluble B chain, and is followed
spectroscopically as an increase in optical density at 650
nm. The solutions were monitored at 30 s intervals over a
period of 80 min.
To test for Dsb-catalyzed refolding of scrambled RNaseA
In vitro isomerase activity of Dsb proteins were assessed
utilizing scRNaseA as previously described [61]. ScRNaseA
was produced by first incubating native RNaseA (Sigma) in
50 mM Tris–HCl, pH 8.0 with 6 M Gdn-HCl and 0.1 M
DTT overnight at room temperature. The reduced, un-
folded RNaseA was acidified with 100 mM acetic acid, pH
4 and purified over a desalting column. The presence of
eight free thiols was confirmed by the Ellman’s assay. To
generate randomly oxidized disulfide bonds in scRNaseA,
reduced RNaseA in 50 mM Tris–HCl pH 8.5 was incu-
bated with 6 M Gdn-HCl in the dark at room temperature
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of the disulfide bonds to produce scRNaseA was confirmed
by the Ellman’s assay.
Isomerase activity of reduced Mt-DsbA and mutants
were tested by measuring spectrophotometrically RNaseA
cleavage of cyclic-2’,3’-cytidinemonophosphate (cCMP) to
3’-cytidinemonophosphate (3’CMP), which results in an in-
crease in absorption at 296 nm. Purified Mt-DsbA or mu-
tants (10 μM) were added to 100 mM sodium phosphate
pH 7, 1 mM EDTA, and 10 μM DTT at room temperature
for 5 minutes. To initiate the reaction, 40 μM scRNaseA
was added. At several time points, 20 μl aliquots were
taken and added to 60 μl of 4 mM cCMP, so that the final
volume was 80 μl. The rate of RNaseA cleavage of cCMP
was monitored at 296 nm for 3 min and the percentage of
native RNaseA activity was plotted against time.
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